July 1982
Volume 23, Issue 1
Articles  |   July 1982
Dynamic changes in the organophosphate profile upon treatment of the crystalline lens with dexamethasone.
Investigative Ophthalmology & Visual Science July 1982, Vol.23, 14-22. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J V Greiner, S J Kopp, T Glonek; Dynamic changes in the organophosphate profile upon treatment of the crystalline lens with dexamethasone.. Invest. Ophthalmol. Vis. Sci. 1982;23(1):14-22.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements
This content is PDF only. Please click on the PDF icon to access.

Dynamic changes in organophosphate metabolites during incubations of the intact crystalline lens in a medium containing 2 X 10(-3) M dexamethasone were studied using phosphorus-31 nuclear magnetic resonance intact-tissue spectroscopy. ATP, ADP, inorganic orthophosphate, alpha-glycerophosphate, nicotinamide adenine dinucleotides, uridine diphosphorylglucose and diphosphorylgalactose, glycerol 3-phosphorylethanolamine and -phosphorylcholine, and an unidentified phosphorus-containing molecule at 6 ppm were quantitated. Time-dependent changes in lens metabolism involving these compounds were examined during a 24-hr incubation period with dexamethasone. The first event in the decline of the tissue after steroid incubation was the consumption of ATP, which was linear with time until the ATP was reduced to 10% of its initial value. The sugar phosphates, inorganic orthophosphate, and the nucleoside diphosphorylsugars increased linearly with time, whereas the dinucleotides decreased. The ADP concentration was unaffected by the steroid treatment, as was that of the other organophosphates in the intact tissue profile. The steroid-induced alterations in lens phosphate metabolite levels follow a distinctive pattern that differs substantially from that observed in response to experimental hypoglycistic or hyperglycistic conditions. These findings suggest that pharmacologic steroid doses may directly alter lens metabolism through a complex mechanism involving, at least in part, a steroid-mediated antagonism of lens glucose uptake and/or utilization.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.